Stocks · Health care · Pharmaceutical Preparations

Cingulate Inc.

CING Clue Score34
United States Fiscal year ends December CIK 0001862150 Results filed 13 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Thomas Jeffrey Hargroves
13 Feb 2026
Director
Buy indirect
97,276
$5.04
$490.27K
Matthew Brams
6 Feb 2026
EVP and Chief Medical Officer
Buy
1,946
$5.04
$9.81K
Shane J. Schaffer
6 Feb 2026
Chief Executive Officer
Buy indirect
6,809
$5.04
$34.32K
Jennifer L. Callahan
6 Feb 2026
SVP and CFO
Buy
4,864
$5.04
$24.51K
Peter J. Werth
6 Feb 2026
Director
Buy indirect
19,455
$5.04
$98.05K

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 51,043
History held since 9 Dec 2021